Download presentation
Presentation is loading. Please wait.
Published byAlisha Campbell Modified over 6 years ago
1
Applications of laser electron accelerators in the range MeV to VHEE radiotherapy G. Grittani, T. Levato, C. Lazzarini and G. Korn ELI-Beamlines, Dolni Brezany (Czech Republic) VHEE’17 Workshop, STFC Daresbury Laboratory,
2
OUTLINE OF THE TALK Laser Plasma Accelerators and ELI-Beamlines
Finding the niche for LPA InstantDose
3
OUTLINE OF THE TALK Laser Plasma Accelerators and ELI-Beamlines
Finding the niche for LPA InstantDose
4
LASER PLASMA ACCELERATORS
To use plasma as an accelerating medium was firstly proposed to achieve higher accelerating gradients. In 2004, first quasimonoenergetic bunches have been accelerated with gradients exceeding 100 MV/mm. RF accelerators Laser Plasma Accelerators Energy Scalable, with accelerating gradients up to 100 MV/m. Energy spread as low as 0.1%. High gradients higher than 100 MV/mm, but energy gain in single stage limited to few GeV. Energy spread of 1 %. Current Peak current limited by the time duration of the bunch, but high average current thanks to the higher frequency. Peak current of few kA, but average current at the nA level for high energies. Quality Very low (µrad) divergence and pointing instability. Beam divergence and pointing stability at the mrad level. Shot-to-shot fluctuations of beam parameters. Synchro Synchronization with other beams limited to the ps level. Synchronization with a laser or radiation beam up to fs level.
5
ELI-BEAMLINES High repetition rate secondary radiation sources by femtosecond lasers: - XUV and X-ray sources (broadband and monoenergetic) Electrons (broadband and quasi-monoenergetic, up to 10 GeV) Protons and heavy ions (1-100 MeV/u) Gamma ray sources (broadband and quasi-monoenergetic)
6
High flexibility experimental platform @ LWFA
THE HELL BEAMLINE Auxiliary movable chamber Main chamber End-station for users L3 laser: 1 PW 30 J in 30 fs @ 10 Hz Counter-propagating beam (not during commisioning) ----- Meeting Notes (21/04/17 00:04) ----- 3 INDEPENDENT DELAY LINES CHAMBER DESIGN FINALIZED AND TENDERING SUPER FLEXIBLE END-STATION FOR EXTERNAL USERS MOVABLE 2ND CHAMBER ns beam High flexibility experimental LWFA
7
STATE OF THE ART Energy control Charge control Stability
Colliding pulse injection SMLWFA / Bubble Longitudinal self-injection Multi-stage acceleration Ionization injection Density ramp
8
STABLE LASER PLASMA ACCELERATOR
Energy stability = 2.5% Charge stability = 12%
9
INNOVATIVE ACCELERATOR
10
OUTLINE OF THE TALK Laser Plasma Accelerators and ELI-Beamlines
Finding the niche for LPA InstantDose
11
Radioisotope production
APPLICATION OF LPA They have to take advantage of compactness and/or high peak current and/or fs synchronization Physics Cancer Therapy Radioisotope production Irradiators QED VHEE Localized production Cutting and welding Imaging Radiobiology Electron radiography Ultrafast femtochemistry
12
QED
13
RADIOBIOLOGY
14
ELECTRON RADIOGRAPHY
15
Outline of the talk Laser Plasma Accelerators and ELI-Beamlines
Finding the niche for LPA InstantDose
16
TEAM Gabriele Maria Grittani Tadzio Levato Carlo Maria Lazzarini
Project Leader Tadzio Levato Research Leader Carlo Maria Lazzarini Researcher Georg Korn Senior Chief Scientist Tomas Mann Business Management
17
RADIOTHERAPY IN THE CZECH REPUBLIC
Radiotherapy is a treatment involving the use of high energy radiation Particle accelerators vs. Radioactive sources Main cancer diagnosis New cases/year Radiotherapy treatments Lung 6242 38,3% Breast (females) 5628 82% Prostate 4289 39% Rectum 2211 82,8% Corpus uteri 1734 58,6% Cervix uteri 1033 78,7% Other without skin 53522 43,0%
18
ASSESSMENT OF VHEE
19
ASSESSMENT OF VHEE Penumbra ≡ distance between 80%
and 20% of dose maximum at a given depth Dose in the channel vs. Dose outside the channel Electrons Gammas Protons Energy (MeV) Dose inside Dose outside 100 0.3523 0.6477 1 0.4782 0.5218 60 0.6147 0.3853 200 0.4491 0.5509 6 0.4046 0.5954 120 0.552 0.448 300 0.4936 0.5064 10 0.3597 0.6403 180 0.4639 0.5361 400 0.5144 0.4856 18 0.318 0.682 250 0.3711 0.6289 700 0.3009 0.6991 25 0.3053 0.6947 1000 0.1912 0.8088 50 0.2772 0.7228 depth (cm) 100 MeV electron 6 MeV gamma 2 0.49 cm 0.65 cm 4 0.53 cm 0.61 cm 6 0.64 cm 0.68 cm 7 0.86 cm 0.67 cm depth (cm) 200 MeV electron 10 MeV gamma 2.5 0.49 cm 0.65 cm 5 0.51 cm 7.5 0.56 cm 0.75 cm 10 0.67 cm 0.87 cm depth (cm) 300 MeV electron 18 MeV gamma 5 0.49 cm 0.67 cm 7.5 0.52 cm 0.74 cm 10 0.56 cm 0.72 cm 12.5 0.64 cm 0.76 cm depth (cm) 400 MeV electron 25 MeV gamma 50 MeV gamma 6 cm 0.63 cm 0.66 cm 10 cm 0.74 cm 0.67 cm 14 cm 0.73 cm 0.72 cm 18 cm 0.89 cm 0.75 cm
20
INITIAL VALUE PROPOSITION
Radio-frequency accelerators Laser-Plasma accelerators Price: 4 Million USD Beam Energy: 6-20 MV Energy gain: 10 MV in 1 meter Discrete dose range Hz, <1 mGy/pulse Treatment time 5-10 minutes Very complex systems Old technology, very reliable Price: <2 Million USD CHEAPER Beam Energy: up to 300 MV BETTER Energy gain: 100 MV in 1 mm Continuous dose range 50 Hz frequency, 100 mGy/pulse Treatment time <1 minute FASTER More simple systems New technology
21
VALIDATION OF THE IDEA (iterative process)
MEDICAL PEOPLE COMMERCIAL PARTNERS More than 20 doctors from 4 different institutions Imaging needed Radioisotope production Device better for lung cancer than for prostate cancer Shielding Weight More accurate treatment (margin reduction) Rental model is very welcome at the hospitals Software is crucial Need to talk with SURO Laser manufacturer has capability of maximum 5 devices/year The laser system we are asking is commercially available Discount of 30% for 3+ laser system/year Joint Venture in Czech Republic if more than 5 devices/year Diagnostic manufacturer can get public funding for R&D Diagnostic are edge of state of the art Diagnostic will cost 1 M€/device
22
THE IDEA X 20 times EXTERNAL X-RAY LPA
Everything happens in less than 100 ms! On-line target region imaging Planned treatment Real treatment
23
INSTANTDOSE HIGHEST DOSE RATE ON THE MARKET REAL-TIME IMAGING
(>20 mGy in less than 1 ps) REAL-TIME IMAGING (time resolution <100 ms) TUNABLE ELECTRON ENERGY (100 different beams in the range MeV) HIGH CUSTOMIZATION (# radiation sources, complex geometry) LOWER COMPLEXITY (no high vacuum, no complex electronics) LONGER LIFETIME (lifetime >10 years with minor replacements) EXTREMELY VERSATILE (dosimetry tests, biomedical research, radioisotope production) LOW FREQUENCY (<10 Hz) INCREASED SHIELDING (higher electron energy) BEAM STABILITY (shot-to-shot fluctuations) TECHNOLOGY DEVELOPMENT RISKS (device automation, increased costs)
24
Future development: POTENTIAL UPGRADES MRI imaging Implementation
Sterilization in-house Radioisotope Production In-house Additional particles
25
PROJECT STATUS AND ROADMAP
IP Protection Patent filed in June 2016 Technical design Doctor’s opinion 6 M Euro Beta-Prototype at 50 MeV, 20 mGy/pulse Software development Certification 10 M Euro Final Prototype at 300 MeV, 100 mGy/pulse Medical tests 7 years
26
THANK YOU FOR YOUR ATTENTION
27
DIAGNOSTICS TEST AT ELETTRA
Spectrum and charge calibration Radiation damage Lanex Regular was burn in 2 hours CCD camera lost 10% of its pixel in 2 days of operation
28
INSTANTDOSE Pulsed Radiation Source Fast-imaging system
On-line target region imaging Radiation Pulse Parameters Planned treatment Real treatment
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.